Vice President Quality and Regulatory Affairs
Position Summary
Our Startup Client is seeking an experienced Vice President of Quality & Regulatory Affairs to lead the Quality and Regulatory functions for a clinical-stage biotechnology company developing innovative cell-based therapies.
This executive will have overall responsibility for establishing and maintaining a phase-appropriate Quality Management System, providing strategic regulatory leadership, and ensuring compliance across clinical development, manufacturing, testing, and external partners.
The VP will serve as a key member of the leadership team and will work closely with Clinical, CMC/Technical Operations, Manufacturing, R&D, and external partners to advance programs through clinical development and toward commercialization.
The successful candidate should be highly hands-on and comfortable operating in a small, fast-paced biotechnology company. This role requires both strategic leadership and the ability to independently assess issues, make risk-based recommendations, and drive execution. The VP will hold independent Quality authority for product disposition and release, maintained separately from Manufacturing and Technical Operations.
Key Responsibilities
Quality Leadership
• Provide executive leadership and oversight for Quality Assurance and Quality Control.
• Establish, maintain, and continuously improve a phase-appropriate Quality Management System (QMS)
supporting clinical-stage cell therapy development.
• Ensure compliance with applicable GMP, GCP, GLP, and other relevant FDA regulatory requirements.
• Provide independent Quality oversight of manufacturing, testing, release, clinical supply, and vendor activities.
• Maintain appropriate Quality independence from Manufacturing and Technical Operations, including
independent authority for product disposition and release. Oversee:
– Deviations and investigations
– Change controls
– Out-of-specification / out-of-trend investigations
– Product complaints
– Document control
– Training systems
– Supplier qualification
– Internal and external audits
– Batch records
– Product disposition and release
– Quality risk management
• Ensure Quality systems evolve appropriately as the company progresses from early clinical development toward
later-stage development and commercialization.
• Establish clear Quality metrics and regularly communicate significant risks, trends, and remediation plans to
executive leadership.
• Develop and execute the company's US regulatory strategy, with expansion into global regulatory activities as
programs advance.
• Serve as a primary strategic interface with the FDA and other regulatory authorities. Lead preparation and review of:
– IND submissions and amendments
– FDA information requests
– Meeting packages
– Annual reports
– Clinical protocol amendments
– Investigator's Brochures
– CMC regulatory submissions
– Safety-related regulatory communications
• Provide strategic guidance on regulatory pathways for cell therapy programs, including early clinical
development, dose escalation, manufacturing changes, comparability, and later-stage development.
• Partner closely with Clinical, CMC, Preclinical, and R&D teams to ensure regulatory strategy is integrated into
development plans.
• Translate regulatory feedback into clear, actionable internal plans.
• Maintain productive and transparent interactions with regulatory authorities.
CMC & Cell Therapy Regulatory Strategy
• Provide regulatory and Quality leadership for cell therapy manufacturing and CMC development. Partner with Technical Operations on:
– Manufacturing process development
– Process qualification and validation strategy
– Analytical method development and validation
– Specifications
– Stability programs
– Raw material controls
– Comparability
– Manufacturing site changes
– Technology transfer
– Supply chain controls
• Assess regulatory impact of manufacturing changes and determine appropriate submission and implementation
strategies.
• Ensure manufacturing controls and documentation are appropriate for the clinical stage while supporting
progression toward commercial readiness.
Clinical Quality
• Provide Quality oversight of clinical development activities.
• Ensure appropriate GCP systems and vendor oversight are established.
• Partner with Clinical Operations on qualification and oversight of CROs, clinical sites, laboratories, and other
service providers.
• Support inspection readiness as the clinical program expands.
Vendor & Consultant Oversight
• Establish a structured approach for qualification and oversight of CROs, CDMOs, testing laboratories,
consultants, and other critical vendors.
• Evaluate external recommendations independently and ensure that final Quality and Regulatory strategies
reflect the company's scientific, operational, and business objectives.
• Build sufficient internal expertise so that critical regulatory and Quality decisions are owned by the company
rather than outsourced to consultants.
• Manage external consultants selectively to supplement, rather than replace, internal leadership.
Organizational Leadership
• Build and mentor a high-performing Quality and Regulatory organization appropriate for the company's stage of
development.
• Lead and develop existing QA/QC personnel and establish clear roles, responsibilities, decision rights, and
escalation pathways.
• Recruit additional Quality and Regulatory personnel as the organization grows.
• Develop future leaders within the Quality organization.
• Promote a culture of accountability, scientific rigor, collaboration, and practical risk management.
• Work collaboratively across functions while maintaining appropriate Quality independence.
Qualifications
Required
• Bachelor's degree in life sciences, engineering, pharmacy, or related discipline; advanced degree preferred.
• Typically 15+ years of progressive experience in biotechnology, pharmaceutical, or cell/gene therapy
development, including significant leadership experience.
• Direct Quality and/or Regulatory leadership experience with cell therapy, gene therapy, or other advanced /
complex biological products — required.
• Demonstrated experience leading Quality and/or Regulatory functions in a clinical-stage biotechnology
company.
• Strong understanding of GMP requirements for clinical manufacturing.
• Experience with IND-stage programs and direct interaction with FDA.
• Demonstrated experience developing regulatory strategy and responding to FDA questions or information
requests.
• Strong knowledge of Quality systems, including deviation management, CAPA, change control, supplier
qualification, audits, and product disposition.
• Experience supporting clinical manufacturing and release of investigational products.
• Experience managing CROs, CDMOs, laboratories, and regulatory/Quality consultants.
• Ability to operate effectively in a small company where executives are expected to work both strategically and
hands-on.
Preferred
• Advanced degree (MS, PhD, PharmD, MD, or equivalent).
• Prior leadership experience specifically in cell therapy, regenerative medicine, xenotransplantation, or other
advanced biologic modalities.
• Experience supporting products from Phase 1 through later-stage clinical development.
• Experience establishing or significantly upgrading a Quality Management System in a growing biotechnology
company.
• Experience with regulatory strategy for manufacturing changes and comparability.
• Experience participating in FDA meetings and regulatory inspections.
• Experience preparing an organization for commercial-stage GMP requirements.
Leadership Profile
The ideal candidate will:
• Exercise independent scientific and regulatory judgment.
• Be comfortable challenging assumptions while remaining pragmatic and solution-oriented.
• Understand the distinction between regulatory requirements, regulatory precedent, and conservative industry
practice.
• Identify practical paths forward rather than simply identifying compliance risks.
• Communicate clearly with executives and technical teams.
• Be willing to make decisions with incomplete information while appropriately managing risk.
• Balance patient safety, regulatory compliance, development speed, and business priorities.
• Operate effectively without a large corporate infrastructure.
• Take ownership of issues and drive them through resolution.
